| | | Human | — | Not specified. | Vitamin D, Calcium Supplements, and Implications for Cardiovascular Health: JACC Focus Seminar. |
| | | Human | — | 2000 mg calcium (combined with 800 IU vitamin D daily). | Vitamin D Supplementation in Military Personnel: A Systematic Review of Randomized Controlled Trials. |
| | | Human | high-risk patients | 1,000 to 1,200 mg of calcium per day; 800 to 2,000 IU of vitamin D3 daily. | Current concept review: vitamin D and stress fractures. |
| | | Human | certain populations | 1,000 to 1,200 mg of calcium per day; 800 to 2,000 IU of vitamin D3 daily. | Current concept review: vitamin D and stress fractures. |
| | | Human | — | 1,000 to 1,200 mg of calcium per day; 800 to 2,000 IU of vitamin D3 daily. | Current concept review: vitamin D and stress fractures. |
| | | Human | — | Not specified | Nutrition, bone, and aging: an integrative physiology approach. |
| | | Human | — | Not specified | Calcium and vitamin D supplementation: when and why. |
| | | Human | adults aged ≥65 years | Not specified | Dietary supplements and disease prevention - a global overview. |
| | | Human | patients on these agents | Not specified | Drugs that may harm bone: Mitigating the risk. |
| | | Human | athletes | Not specified | Considerations for the Consumption of Vitamin and Mineral Supplements in Athlete Populations. |
| | | Human | — | Not specified | B vitamins, homocysteine and bone health. |
| | | Human | patients during treatment for breast cancer | Not specified | Bone Health Considerations in Breast Cancer. |
| | | Human | women with FF VDR genotype | 600 mg once daily as CaCO3 | Change of BMD after weaning or resumption of menstruation in Chinese women with different FokI VDR-genotypes: a randomized, placebo-controlled, calcium supplementation trial. |
| | | Human | — | Not specified | Therapeutic options in osteoporosis. |
| | | Human | premenopausal women with breast cancer | Daily calcium supplementation (specific dosage not mentioned). | Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention? |
| | | Human | women with a Z-score <-2.0 or Z-score ≤-1.0 and/or a 5-10% annual decrease in bone mineral density | Daily calcium supplementation (specific dosage not mentioned). | Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention? |
| | | Human | community-dwelling adults | Greater than 400 IU vitamin D3 and greater than 1000 mg calcium (for postmenopausal women); ≤400 IU vitamin D3 and ≤1000 mg calcium (not recommended). | Vitamin D and calcium supplementation to prevent fractures in adults: U.S. Preventive Services Task Force recommendation statement. |
| | | Human | postmenopausal women in north of China | 300, 600, and 900 mg/day of calcium (groups A, B, and C, respectively) with 800 IU/day of vitamin D. | Effect of Milk Powder Supplementation with Different Calcium Contents on Bone Mineral Density of Postmenopausal Women in Northern China: A Randomized Controlled Double-Blind Trial. |
| | | Human | adults and children with celiac disease | Not specified | Management of bone health in patients with celiac disease: Practical guide for clinicians. |
| | | Human | women at high risk of osteoporosis | Not specified | Effects of a three-month therapeutic lifestyle modification program to improve bone health in postmenopausal Korean women in a rural community: a randomized controlled trial. |
| | | Human | patients with inflammatory bowel disease | Not specified | Pediatric inflammatory bowel disease and bone health. |
| | | Human | T1DM in resource limited settings | Group A received 200 ml milk + 1000 IU vitamin-D3/day; Group B received 500 mg calcium carbonate + 1000 IU vitamin-D3/day. | Effect of Calcium and Vitamin D Supplementation (Dairy vs. Pharmacological) on Bone Health of Underprivileged Indian Children and Youth with Type-1 Diabetes: A Randomized Controlled Trial. |
| | | Human | — | Not specified | Osteoporosis diagnosis and medical treatment. |
| | | Human | those who are deficient in these nutrients | Not specified | Cardiovascular safety of calcium, magnesium and strontium: what does the evidence say? |
| | | Human | — | Not specified | Influence of calcium supplements on the occurrence of cardiovascular events. |
| | | Human | pregnant women with low calcium intakes | 1500 mg Ca/day (as calcium carbonate). | Effect of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake. |
| | | Human | patients with epidermolysis bullosa (EB) | Not specified | Osteopenia and osteoporosis in epidermolysis bullosa. |
| | | Human | underprivileged premenarchal girls | 500 mg/d calcium (Ca-group), 500 mg/d calcium + multivitamin tablet containing 15 mg/d zinc (Ca+MZ-group). | School-based calcium-vitamin D with micronutrient supplementation enhances bone mass in underprivileged Indian premenarchal girls. |
| | | Animal | our model | Not specified | Lessons from rodent gastric bypass model of enteric hyperoxaluria. |
| | | Human | patients receiving ADT | Not specified | Adverse effects of androgen deprivation therapy in patients with prostate cancer: Focus on muscle and bone health. |
| | | Human | adolescents with NTD Hb E/β-thalassemia | Not specified | Prevalence of low bone mass among adolescents with nontransfusion-dependent hemoglobin E/β-thalassemia and its relationship with anemia severity. |
| | | Human | maternal participants during pregnancy | Individualized high dairy protein diet (specific amounts not detailed). | Individualized high dairy protein + walking program supports bone health in pregnancy: a randomized controlled trial. |
| | | Human | postmenopausal women with osteoporosis | 1,200 mg calcium carbonate and 400 IU vitamin D3 daily. | Is a lower dose of vitamin D supplementation enough to increase 25(OH)D status in a sunny country? |
| | | Human | postmenopausal women | Not specified | Vitamin D and calcium: what do we need to know? |
| | | Human | patients assessed for fracture risk | Not specified | Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). |
| | | Human | all patients with chronic liver disease | — | Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications. |
| | | Human | individuals with Rett syndrome | Not specified | Clinical Guidelines for Management of Bone Health in Rett Syndrome Based on Expert Consensus and Available Evidence. |
| | | Human | critically ill populations | Not specified | Micronutrient intake to protect against osteoporosis during and after critical illness. |
| | | Human | men treated with ADT for prostate cancer | Not specified | Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial. |
| | | Human | elderly | 500 mg calcium citrate daily. | Evaluating adherence, tolerability and safety of oral calcium citrate in elderly osteopenic subjects: a real-life non-interventional, prospective, multicenter study. |
| | | Human | postmenopausal women receiving AIs | Not specified | Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors. |
| | | Human | — | Not specified | The role of carotenoids in bone health-A narrative review. |
| | | Human | postmenopausal women | — | A review of select vitamins and minerals used by postmenopausal women. |
| | | Human | — | Not specified | Calcium and Vitamin D Deficiency in Vietnamese: Recommendations for an Intervention Strategy. |
| | | Human | older population | — | The cardiovascular safety aspects of calcium supplementations: where does the truth lie? A personal perspective. |
| | | Human | young adults entering IMT | 2000 mg calcium and 1000 IU vitamin D daily. | Association Between Single Gene Polymorphisms and Bone Biomarkers and Response to Calcium and Vitamin D Supplementation in Young Adults Undergoing Military Training. |
